ATE306927T1 - Verfahren und mittel zur verminderung der tumorentwicklung mittels einer kombination aus einer taxanverbindung und einer tellur und/oder selenverbindung - Google Patents

Verfahren und mittel zur verminderung der tumorentwicklung mittels einer kombination aus einer taxanverbindung und einer tellur und/oder selenverbindung

Info

Publication number: ATE306927T1
Authority: AT; Austria
Prior art keywords: compound; tellurium; combination; tumor development; reducing tumor
Prior art date: 1994-12-15

Application number

AT95942611T

Other languages

English (en)

Inventor

Benjamin Sredni

Howard B Bruckner

Michael Albeck

John Whisnant

Karl L Mettinger

Original Assignee

Baker Norton Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-12-15

Filing date

1995-12-12

Publication date

2005-11-15

1995-12-12 Application filed by Baker Norton Pharma filed Critical Baker Norton Pharma

2005-11-15 Application granted granted Critical

2005-11-15 Publication of ATE306927T1 publication Critical patent/ATE306927T1/de

Links

-1 TAXANE COMPOUND Chemical class 0.000 title abstract 3
229940123237 Taxane Drugs 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
229940065287 selenium compound Drugs 0.000 title abstract 2
150000003343 selenium compounds Chemical class 0.000 title abstract 2
229910052714 tellurium Inorganic materials 0.000 title abstract 2
PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 title abstract 2
230000005748 tumor development Effects 0.000 title 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 abstract 1
206010028980 Neoplasm Diseases 0.000 abstract 1
229930012538 Paclitaxel Natural products 0.000 abstract 1
238000002648 combination therapy Methods 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000036210 malignancy Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
229960001592 paclitaxel Drugs 0.000 abstract 1
RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT95942611T 1994-12-15 1995-12-12 Verfahren und mittel zur verminderung der tumorentwicklung mittels einer kombination aus einer taxanverbindung und einer tellur und/oder selenverbindung ATE306927T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US35712894A	1994-12-15	1994-12-15
PCT/US1995/016097 WO1996018401A1 (en)	1994-12-15	1995-12-12	Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound

Publications (1)

Publication Number	Publication Date
ATE306927T1 true ATE306927T1 (de)	2005-11-15

Family

ID=23404413

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT95942611T ATE306927T1 (de)	1994-12-15	1995-12-12	Verfahren und mittel zur verminderung der tumorentwicklung mittels einer kombination aus einer taxanverbindung und einer tellur und/oder selenverbindung

Country Status (6)

Country	Link
EP (1)	EP0793499B1 (de)
JP (1)	JPH10510812A (de)
AT (1)	ATE306927T1 (de)
AU (1)	AU699442B2 (de)
DE (1)	DE69534535T2 (de)
WO (1)	WO1996018401A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6103698A (en)	1997-03-13	2000-08-15	Basf Aktiengesellschaft	Dolastatin-15 derivatives in combination with taxanes
AU2004304716B2 (en)	2003-12-18	2010-05-27	Biomas Ltd.	Tellurium derivatives for prevention and treatment of neurodegenerative processes
EP1791535B1 (de)	2004-09-17	2008-07-30	BioMAS Ltd.	Neue tellurium-verbindungen und ihre verwendung als immunmodulatoren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0182317A2 (de) *	1984-11-20	1986-05-28	Nippon Kayaku Kabushiki Kaisha	Antineoplastisches Mittel
US4761490A (en) *	1985-03-15	1988-08-02	Bar-Ilan University	Organic derivatives of tellurium and selenium and their use to stimulate cytokine production
US4962207A (en) *	1985-09-30	1990-10-09	Bar-Ilan University	Organic derivatives of tellurium and selenium
FR2601675B1 (fr) *	1986-07-17	1988-09-23	Rhone Poulenc Sante	Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US4876399A (en) *	1987-11-02	1989-10-24	Research Corporation Technologies, Inc.	Taxols, their preparation and intermediates thereof
US4946437A (en) *	1988-12-02	1990-08-07	Bar-Ilan University	Method for the stimulation of bone marrow cells
US5262149A (en) *	1992-08-13	1993-11-16	Benjamin Sredni	Method of treating or preventing alopecia

1995
- 1995-12-12 DE DE69534535T patent/DE69534535T2/de not_active Expired - Fee Related
- 1995-12-12 AT AT95942611T patent/ATE306927T1/de not_active IP Right Cessation
- 1995-12-12 WO PCT/US1995/016097 patent/WO1996018401A1/en not_active Ceased
- 1995-12-12 JP JP8519214A patent/JPH10510812A/ja not_active Ceased
- 1995-12-12 EP EP95942611A patent/EP0793499B1/de not_active Expired - Lifetime
- 1995-12-12 AU AU43778/96A patent/AU699442B2/en not_active Ceased

Also Published As

Publication number	Publication date
WO1996018401A1 (en)	1996-06-20
JPH10510812A (ja)	1998-10-20
EP0793499A4 (de)	2000-11-08
AU4377896A (en)	1996-07-03
DE69534535D1 (de)	2006-03-02
EP0793499A1 (de)	1997-09-10
DE69534535T2 (de)	2006-07-06
EP0793499B1 (de)	2005-10-19
AU699442B2 (en)	1998-12-03

Similar Documents

Publication	Publication Date	Title
ATE407683T1 (de)	2008-09-15	Pharmazeutische zusammensetzungen enthaltend arsentrioxid zur behandlung von multiplen myelom
BR9502707A (pt)	1996-06-04	Composto composição farmacêutica e método para o tratamento de uma afecção
DK0490077T3 (da)	1998-01-26	Antisense-oligonukleotider til behandling af cancer
DE69830072D1 (de)	2005-06-09	Radioaktive zusammensetzungen zur behandlung von prostatatumoren
ATE538794T1 (de)	2012-01-15	Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
WO2001066103A3 (en)	2002-03-21	Treatment of neoplasms by inhalation of carboplatin
TR200000576T1 (tr)	2000-11-21	Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem
DE69942827D1 (de)	2010-11-18	Verwendung der epothilons zur behandlung der krebs
BRPI0411239A (pt)	2006-07-18	composto, processo para preparar o mesmo, composição farmacêutica, método para tratar ou prevenir um distúrbio que requer inibição de canal de potássio, e, uso de um composto
DE69430611D1 (de)	2002-06-20	Phosphonooxymethyl oder Methylthiomethylether von Taxanderivaten als Antitumormittel
DE602004025726D1 (de)	2010-04-08	Pharmazeutische verbindung zur behandlung von lokal fortgeschrittenem primär inoperablen pankreaskarzinom (lapc).
WO2004006842A3 (en)	2004-05-27	Combinations of drugs for the treatment of neoplasms
BR0213424A (pt)	2004-12-14	Uso aperfeiçoado de composto antitumoral na terapia contra câncer
DE69927688D1 (de)	2006-02-23	Antivirales Mittel in Kombination mit Strahlentherapie zur Verwendung in der Behandlung von Krebs
DK71387A (da)	1987-08-25	Terapeutisk middel til behandling af psoriasis
WO2004007676A3 (en)	2004-04-08	Combination therapy for the treatment of neoplasms
BR0309996A (pt)	2005-02-22	Composto, composição farmacêutica, método de tratar ou melhorar doenças ou condições proliferativas, uso de um composto, e, método de tratar ou melhorar doenças inflamatórias
ATE306927T1 (de)	2005-11-15	Verfahren und mittel zur verminderung der tumorentwicklung mittels einer kombination aus einer taxanverbindung und einer tellur und/oder selenverbindung
ATE281841T1 (de)	2004-11-15	Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen
ATE486567T1 (de)	2010-11-15	Orale zusammensetzung mit einer ersten zusammensetzung (a) und einer zweiten zusammensetzung (b) zur verwendung als gemische zur getrennten oder aufeinanderfolgenden verwendung in der kosmetischen behandlung des menschlichen körpers
DE69301750D1 (de)	1996-04-18	Verwendung von 1-Alpha,24(R)-Dihydroxy-22(E)-Dehydrovitamin-D3 zur Herstellung eines Arzneimittels zur Behandlung der Osteoporose
DE69815100D1 (de)	2003-07-03	Zusammensetzungen, die dolastatin-15-analoge in kombination mit taxane und dessen derivaten enthalten
CA2206566A1 (en)	1996-06-20	Method and composition for reducing tumor development with a combination of platinum and tellurium or selenium compounds
PT100111A (pt)	1993-06-30	Composicao para o tratamento de um mamifero sofrendo de doenca proliferativa dapele, benigna ou maligna, compreendendo um analogo de somatostatina
CA2206567A1 (en)	1996-06-20	Method and composition for reducing tumor development with a combination of a taxane compound and a tellurium and/or selenium compound

Legal Events

Date	Code	Title	Description
2006-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties